Theophylline and aminophylline and derivatives
HS-Code 293950
Supply Chain Analysis
38 entities · 2024 · exports
Source Countries
Trade Value
Total Quantity
Avg per Entity
Top 5 Concentration
Value Distribution (Top 5)
Efficiency Quadrant — Unit Price vs Order Value
Premium · Volume Player · Niche · Weak
India
$0.04B
44.18% share
European Union
$0.02B
17.41% share
China
$0.01B
14.72% share
Few dominant players — high dependency risk.
Share Split
Top Exporting Countries
| # | Country | Share | Value | 1Y Growth | 3Y Growth | Signal |
|---|---|---|---|---|---|---|
| 1 | 44.18% | $0.04B | +4.73% | +29.94% | 🐢 Slowing | |
| 2 | European Union | 17.41% | $0.02B | +17.12% | +41.38% | 🐢 Slowing |
| 3 | 14.72% | $0.01B | +50.38% | +20.55% | 🚀 Breakout | |
| 4 | 8.90% | $0.01B | -5.75% | +81.13% | ⚠ Momentum Lost | |
| 5 | 5.40% | $0.00B | -20.51% | -14.69% | 📉 Sustained Drop |
Top Importing Countries
| # | Country | Share | Value | 1Y Growth | 3Y Growth | Signal |
|---|---|---|---|---|---|---|
| 1 | 9.82% | $0.01B | +63.48% | +463.41% | 🐢 Slowing | |
| 2 | 8.71% | $0.01B | -20.50% | +39.15% | ⚠ Momentum Lost | |
| 3 | Korea, Rep. | 7.43% | $0.00B | +28.90% | +14.53% | 📈 Accelerating |
| 4 | Egypt, Arab Rep. | 6.80% | $0.00B | -- | -- | → Stable |
| 5 | 6.07% | $0.00B | +59.26% | +286.26% | 🐢 Slowing |
Value vs YoY Growth
Bubble size = market share · Right + Up = high value, high growth
Demand Market Analysis
83 entities · 2024 · imports
Buyer Countries
Trade Value
Total Quantity
Avg per Entity
Top 5 Concentration
Value Distribution (Top 5)
Efficiency Quadrant — Unit Price vs Order Value
Premium · Volume Player · Niche · Weak
United States
$0.01B
9.82% share
Italy
$0.01B
8.71% share
Korea, Rep.
$0.00B
7.43% share
Balanced market — moderate negotiation leverage.
Share Split
Global Trade Map
Exports + Imports by country (hover for details)
Explore more products
Access full trade data across our entire product database.
Have an account? Sign in